ArticleJournal of pharmacy & bioallied sciences2025
Formulation and Characterization of Vitamin D3
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- DFDBA plus T-PRF with and without vitamin D3 gel in intrabony defects: a randomized controlled trial.Odontology · 2026Article
- Evaluation of locally delivered Vitamin D3 gel in nonsurgical periodontal therapy - A randomized controlled trial.Dental research journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study introduces a novel fast-setting Methods: The vitamin D3 formulation was prepared using cold method for Results: The gel demonstrated favorable clarity, almost neutral pH (6.11), thermoreversible gelation, stable at room temperature, viscosity 32500 cps, good spreadability 2.75 gm.cm/sec, drug release 82.86% after 20 h and antimicrobial activity, making it a promising candidate for clinical applications. Conclusion: The vitamin D3-enriched Poloxamer-P407
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.